Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marissa J Scandlyn

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Life Sciences|September 2, 2006
Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancerEmma C Stuart, Marissa J Scandlyn, Rhonda J Rosengren
Expert Opinion on Drug Metabolism & Toxicology|June 5, 2008
Sex-specific differences in CYP450 isoforms in humansMarissa J Scandlyn, Emma C Stuart, Rhonda J Rosengren
International Journal of Oncology|July 12, 2013
Raloxifene reduces triple-negative breast cancer tumor growth and decreases EGFR expressionSebastien Taurin, Kirstie M Allen, Marissa J Scandlyn, et al.
Life Sciences|November 22, 2005
Curcumin modulates drug metabolizing enzymes in the female Swiss Webster mouseSophie P Valentine, Martin J Le Nedelec, Anna R Menzies, et al.
International Journal of Cancer|December 22, 2007
The combination of epigallocatechin gallate and curcumin suppresses ER alpha-breast cancer cell growth in vitro and in vivoTiffany J Somers-Edgar, Marissa J Scandlyn, Emma C Stuart, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Life Sciences|September 2, 2006
Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancerEmma C Stuart, Marissa J Scandlyn, Rhonda J Rosengren
Expert Opinion on Drug Metabolism & Toxicology|June 5, 2008
Sex-specific differences in CYP450 isoforms in humansMarissa J Scandlyn, Emma C Stuart, Rhonda J Rosengren
International Journal of Oncology|July 12, 2013
Raloxifene reduces triple-negative breast cancer tumor growth and decreases EGFR expressionSebastien Taurin, Kirstie M Allen, Marissa J Scandlyn, et al.
Life Sciences|November 22, 2005
Curcumin modulates drug metabolizing enzymes in the female Swiss Webster mouseSophie P Valentine, Martin J Le Nedelec, Anna R Menzies, et al.
International Journal of Cancer|December 22, 2007
The combination of epigallocatechin gallate and curcumin suppresses ER alpha-breast cancer cell growth in vitro and in vivoTiffany J Somers-Edgar, Marissa J Scandlyn, Emma C Stuart, et al.
Pageof 1